Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For META
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.36 2.68 2.67
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 28.16 0.29 -0.23
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.57 58.75 59.69
Cash -10.27 22.87 25.49
Capex 15.81 -2.51 -2.99
Free Cash Flow 10.33 5.05 4.57
Revenue -8.36 14.32 15.63
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 1.27 0.82 0.81
Operating Margin -7.20 0.38 0.41
ROA -9.07 0.06 0.06
ROE -9.61 0.08 0.09
ROIC -0.99 0.07 0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of META is permitted for members.
5 Growth
The "Growth Entry" for the Focus of META is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of META is permitted for members.